Vir Biotechnology (VIR) Gross Margin (2020 - 2026)
Vir Biotechnology (VIR) recorded Gross Margin of 100.00% in Q3 2026, up 4.58 percentage points from 95.42% a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Vir Biotechnology (VIR) Gross Margin (2020 - 2026) Analysis & Trends
On a TTM basis, Vir Biotechnology's Gross Margin came in at 100.06% as of Sep 30, 2026, up 4.24 percentage points year-over-year; for FY2025, it came in at 99.96%, up 1.10 percentage points from FY2024.
- Annual Gross Margin has increased for three straight years, though with a five-year change of -0.04 percentage points (FY2020 to FY2025).
- Across earlier years, Gross Margin came in at 98.86% in FY2024 (+2.07 pp), 96.79% in FY2023 (+5.85 pp), 90.94% in FY2022 (-3.04 pp) and 93.99% in FY2021 (-6.01 pp).
- On a year-over-year basis, Gross Margin rose in five of the last seven quarters, with an average year-over-year change of +1.23 percentage points.
- Peak year-over-year performance for Gross Margin in the last five years was a gain of 68.14 percentage points in Q2 2023, against a drop of 68.08 percentage points in Q2 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.03% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 75.71% |
| 10 | Vir Biotechnology | 2.23 Bn | 313.19 Mn | 188,000.00 | 100.00% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 100.00% |
| Jun 30, 2026 | 100.00% |
| Mar 31, 2026 | -41.38% |
| Dec 31, 2025 | 99.96% |
| Sep 30, 2025 | 95.42% |
| Jun 30, 2025 | 99.09% |
| Mar 31, 2025 | 100.00% |
| Dec 31, 2024 | 94.47% |
| Sep 30, 2024 | 97.90% |
| Jun 30, 2024 | 98.31% |
| Mar 31, 2024 | 99.90% |
| Dec 31, 2023 | 95.25% |
| Sep 30, 2023 | 98.56% |
| Jun 30, 2023 | 99.42% |
| Mar 31, 2023 | 96.97% |
| Dec 31, 2022 | 87.86% |
| Sep 30, 2022 | 94.06% |
| Jun 30, 2022 | 31.28% |
| Mar 31, 2022 | 92.69% |
| Dec 31, 2021 | 93.00% |
API Access
Vir Biotechnology Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();